`Rigged’ system blocks use of lower-cost drugs, FDA chief says

CVS HEALTH'S pharmacy benefit management business came under fire, along with other PBMs, from the head of the Food and Drug Administration for holding drug prices artificially high. / BLOOMBERG FILE PHOTO/MICHAEL NAGLE
CVS HEALTH'S pharmacy benefit management business came under fire, along with other PBMs, from the head of the Food and Drug Administration for holding drug prices artificially high. / BLOOMBERG FILE PHOTO/MICHAEL NAGLE
WASHINGTON – A “rigged payment scheme” between drug plans, insurers and pharmaceutical companies has blocked access to less-expensive versions of some of the most costly drugs in…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

- Advertisement -